|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226
Submitted 4 December 2002 ; accepted in final form 3 February 2003
The relative roles of free-radical production, mitochondrial ATP-sensitive
K+ (mitoKATP) channels and possible receptor cross-talk
in both opioid and adenosine A1 receptor (A1AR) mediated
protection were assessed in a rat model of myocardial infarction.
Sprague-Dawley rats were subjected to 30 min of occlusion and 90 min of
reperfusion. The untreated rats exhibited an infarct of 58.8 ± 2.9%
[infarct size (IS)/area at risk (AAR), %] at the end of reperfusion.
Pretreatment with either the nonselective opioid receptor agonist morphine or
the selective A1AR agonist 2-chloro-cyclopentyladenosine (CCPA)
dramatically reduced IS/AAR to 41.1 ± 2.2% and 37.9 ± 5.5%,
respectively (P < 0.05). Protection afforded by either morphine or
CCPA was abolished by the reactive oxygen species scavenger
N-(2-mercaptopropionyl)glycine or the mitoKATP channel
blocker 5-hydroxydecanoate. Both morphine- and CCPA-mediated protection were
attenuated by the selective A1AR antagonist
1,3-dipropyl-8-cyclopentylxanthine and the selective
1-opioid receptor (DOR) antagonist 7-benzylidenealtrexone.
Simultaneous administration of morphine and CCPA failed to enhance the
infarct-sparing effect of either agonist alone. These data suggest that both
DOR and A1AR-mediated cardioprotection are mitoKATP and
reactive oxygen species dependent. Furthermore, these data suggest that there
are converging pathways and/or receptor cross-talk between A1AR-
and DOR-mediated cardioprotection.
reactive oxygen species; ATP-sensitive potassium channel
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |